Clinical Trials Directory

Trials / Completed

CompletedNCT02481583

Pharmacokinetic Study of Levosulpiride

Tolerability and Pharmacokinetic Comparison of Oral, Intramuscular and Intravenous Administration of Levosulpiride After Single and Multiple Doses in Fasting Healthy Chinese Volunteers

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
42 (actual)
Sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Academic / Other
Sex
All
Age
19 Years – 45 Years
Healthy volunteers
Accepted

Summary

The aim of this study was to characterise the pharmacokinetic properties and assess the safety of different formulations of levosulpiride in healthy Chinese volunteers.

Detailed description

Levosulpiride was administered to 42 healthy male and female (1:1) subjects as tablet (orally) and injection (intramuscularly and intravenously) formulations. Blood samples were collected at regular intervals after single and multiple drug administration. The concentration of levosulpiride in plasma was determined using a validated high performance liquid chromatography-tandem mass spectrometry method. Non-compartmental analysis was performed to estimate pharmacokinetic parameters. The analysis of variance was used to test for linearity and assess the effect of gender on the pharmacokinetic properties of the study drug. Adverse effects were monitored using investigators' questionnaires and subjects' spontaneous reports, vital sign measurements, hematology, clinical chemistry, and electrocardiogram.

Conditions

Interventions

TypeNameDescription
DRUGLevosulpiridedifferent formulations of levosulpiride

Timeline

Start date
2013-03-01
Primary completion
2013-05-01
Completion
2013-05-01
First posted
2015-06-25
Last updated
2015-06-25

Source: ClinicalTrials.gov record NCT02481583. Inclusion in this directory is not an endorsement.

Pharmacokinetic Study of Levosulpiride (NCT02481583) · Clinical Trials Directory